企业QQ
官方微信
Cat.No.: nCov-500
INTENDED USE:
This kit is used forin vitro rapid qualitative detection of novel coronavirus (SARS-CoV-2) antigensin pharyngeal and nasal swab samples. The product is designed to be used forpopulation screening early phase for disease outbreaks. Testing is limited tolaboratories certified. Results are for the identification of SARS-CoV-2nucleocapsid antigen. This antigen is generally detectable in upper respiratorysamples during the acute phase of infection.
SARS-CoV-2Antigen Rapid Test Kit provides preliminary test results, with negativeresults don’tpreclude SARS-CoV-2 infection. Cannot be used as the sole basis for treatmentor other management decision. For in vitro diagnostic use only.SUMMARY AND EXPLANATION:
Novel coronaviruspneumonia (Coronavirus disease 19, COVID-19) is an infectious disease caused bySARS- CoV-2 infection. On February 11, 2020 the International Committee forTaxonomy of Viruses (ICTV) renamed the virus SARS-CoV-2.Its clinicalmanifestations contain fever, fatigue, and dry cough. A few patients have nasalcongestion, runny nose, and sore throat and diarrhea and other symptoms. Insevere cases, dyspnea and / or hypoxemia usually occurs after one week. Somecritical patients show distress syndrome, septic shock, metabolic acidosis thatis difficult to correct, and rapidly develop coagulopathy.
Click link below to download Instruction For Use（EN）：
https://www.dropbox.com/s/g8h0ui8wd3opj6z/Instruction%20for%20Use%20of%20NOVA%20Test%20SARS-CoV-2%20Antigen%20Rapid%20Test%20kit.pdf?dl=0